FDA 483 - Nader Iskander, M.D. - August 06, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Nader Iskander, M.D., a clinical investigator in San Antonio, TX, was cited for two significant observations during an FDA inspection. The firm failed to conduct an investigation in accordance with the signed statement of investigator and investigational plan, including issues with subject eligibility and measurement scales. Additionally, the firm failed to obtain informed consent from human subjects using the most current IRB-approved version prior to drug administration and study-related tests.
ID · e52e30e3-33fa-40f5-8ce1-49466ca41591